卵巢静脉栓塞与盆腔静脉丛栓塞治疗盆腔静脉疾病的12个月随访比较
该回顾性队列纳入72例非梗阻性盆腔静脉疾病女性,比较卵巢静脉栓塞(OVEA)与盆腔静脉丛栓塞(PVPE)的12个月结局。PVPE组慢性盆腔痛、性交痛及性交后疼痛的VAS评分显著低于OVEA组,复发率亦显著更低。
要点
- PVPE组12个月慢性盆腔痛、性交痛、性交后疼痛VAS评分显著低于OVEA组。
- PVPE组复发2例,显著低于OVEA组的9例(P=.036)。
- 两组技术成功率均为100%。
核心结论
- 在非梗阻性盆腔静脉疾病患者中,盆腔静脉丛栓塞可能提供更好的症状缓解并降低复发率。
研究设计与样本
- 回顾性队列研究,纳入2022至2024年间接受经皮腔内静脉栓塞的72例盆腔静脉疾病女性,分为OVEA组与PVPE组。
主要发现
- 第12个月时,PVPE组慢性盆腔痛VAS评分显著低于OVEA组(P=.001)。
- PVPE组性交痛VAS评分显著低于OVEA组(P=.008)。
- PVPE组性交后疼痛VAS评分显著低于OVEA组(P=.005)。
- PVPE组复发2例,显著低于OVEA组的9例(P=.036)。
- 平均诊断时间为34.98±9.03个月。
临床怎么用
- 对于非梗阻性盆腔静脉疾病患者,可考虑采用盆腔静脉丛栓塞以改善12个月症状缓解并降低复发。
局限性
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Percutaneous endovenous embolization has emerged as a treatment of choice for nonobstructive pelvic venous disorders (PeVD) due to its effectiveness, ease of application, and less invasiveness compared with surgical interventions. In this study, we aimed to analyze 12-month outcomes of the pelvic venous plexus embolization (PVPE) approach and the ovarian vein embolization alone (OVEA) approach. METHODS: This retrospective cohort included 72 women with PeVD who underwent percutaneous endovenous embolization between 2022 and 2024. Patients were assigned to OVEA or PVPE. Symptoms such as chronic pelvic pain, dyspareunia, postcoital pain, and dysmenorrhea were assessed using the visual analog scale at baseline and 12 months. Bladder symptoms were recorded as present/absent. Recurrence was defined as reappearance or worsening of symptoms within 12 months postprocedure. The primary outcome was 12-month symptom relief; secondary outcomes were recurrence and complications. RESULTS: Technical success rate was 100%. Visual analog scale scores for chronic pelvic pain, dyspareunia, and postcoital pain at the 12th month were significantly lower in the PVPE group compared with OVEA (P = .001, P = .008, and P = .005, respectively). Recurrence was statistically significantly lower in two patients in the PVPE group compared with nine patients in the OVEA group (P = .036). The mean diagnosis time was found to be 34.98 ± 9.03 months. CONCLUSIONS: PeVD is a heterogeneous clinical condition in which both venous reflux and venous outflow obstruction may contribute to symptom development. Our study demonstrated that, in patients with nonobstructive PeVD, the PVPE approach may provide better symptomatic relief and reduced recurrence rates. Long-term results of this approach should be supported by further studies to reach a more solid scientific basis for the management of PeVD.
引用
- Karakaya HC, Ariturk C. Comparison of ovarian vein embolization alone with pelvic venous plexus embolization in the treatment of pelvic venous disorders at 12-month follow-up. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41974369. doi:10.1016/j.jvsv.2026.102502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。